Funded Startups in Beverly
In Beverly, the largest disclosed round is $75M for Highland Electric Fleets on 2026-06-02, and it sits far above the next-highest disclosed amounts ($37M…
In Beverly, the largest disclosed round is $75M for Highland Electric Fleets on 2026-06-02, and it sits far above the next-highest disclosed amounts ($37M for Nth Cycle on 2023-12-04 and $12M for BioVie on 2025-08-07). The list also shows a tight temporal cluster: five rounds with disclosed amounts fall between 2024-06-21 (New Frontier Bio) and 2024-09-24 (BioVie), including two BioVie financings ($3M on 2024-09-24 and $12M on 2025-08-07) and back-to-back 2024 biotech rounds such as Endolytix ($5M on 2024-08-07). Sector-wise, biotech is the dominant repeat theme across the 13 rows, appearing in at least 6 entries (BioVie, Endolytix, New Frontier Bio, seqWell, Akston Biosciences, and LeviSense Medical), while stage labeling is frequently not specified: 7 of 13 rows are “Series Unknown.” Rounds span from 2022-03-22 (LeviSense Medical) through 2026-06-02 (Highland Electric Fleets), with the most recent filing on 2026-06-02.
Most recent rounds
13 shownRelated listings
Frequently asked
What stands out most in round size for Beverly, and how does it compare to the rest of the disclosed deals?
Highland Electric Fleets raised $75M on 2026-06-02, which dwarfs the rest of the disclosed amounts in the table. The next-largest disclosed rounds are $37M (Nth Cycle on 2023-12-04) and $12M (BioVie on 2025-08-07).
Is there a concentration of funding activity in a narrow date window?
Yes. Between 2024-06-21 (New Frontier Bio, $310K) and 2024-09-24 (BioVie, $3M), three disclosed biotech rounds appear in a tight span (New Frontier Bio, Endolytix $5M on 2024-08-07, and BioVie’s $3M on 2024-09-24). A separate high point is Nth Cycle’s $37M on 2023-12-04, which anchors the late-2023 period.
Which sectors are most represented, and do they cluster around specific types of rounds?
Biotechnology is the most frequent sector, appearing in at least 6 of 13 rows (BioVie, Endolytix, New Frontier Bio, seqWell, Akston Biosciences, LeviSense Medical). Other sectors appear less often, including Transportation (Highland Electric Fleets, $75M on 2026-06-02) and Data and Analytics (Fluid-Screen, $1M on 2022-05-31).
How much of the stage information is specified versus missing on these recent Beverly deals?
Stage labels are frequently unspecified: 7 of 13 rows are “Series Unknown.” Only a smaller subset is explicitly labeled, such as Nth Cycle (Series B, $37M on 2023-12-04), Fluid-Screen (Series A, $1M on 2022-05-31), and LeviSense Medical (Seed, $300K on 2022-03-22).
Are there notable outliers besides the largest round?
Yes on both ends. The smallest disclosed amount is $200K for Prospective Research (debt financing) on 2022-08-12, while 3EO Health on 2023-06-06 is listed as “undisclosed,” making it a non-comparable outlier versus disclosed amounts. Sector-wise, the table also separates out Transportation (Highland Electric Fleets, $75M) from the multi-entry biotech cluster.
Which entries fall near the most recent period shown, and what does that imply about current momentum?
The two latest rounds in the table are Highland Electric Fleets on 2026-06-02 ($75M) and BioVie on 2025-08-07 ($12M). Together with BioVie’s earlier financing in 2024-09-24 ($3M), the pattern suggests ongoing activity from at least one biotech name rather than a broad late-stage spread across many sectors.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.